FAM82B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.250800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.954400E-01
Normal-vs-Stage2
3.017800E-01
Normal-vs-Stage3
1.028650E-01
Normal-vs-Stage4
5.004200E-01
Stage1-vs-Stage2
8.564400E-01
Stage1-vs-Stage3
3.835200E-01
Stage1-vs-Stage4
8.823200E-01
Stage2-vs-Stage3
3.587600E-01
Stage2-vs-Stage4
7.393000E-01
Stage3-vs-Stage4
3.602400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.240600E-01
Normal-vs-AfricanAmerican
1.441170E-01
Normal-vs-Asian
1.889390E-01
Caucasian-vs-AfricanAmerican
3.641600E-01
Caucasian-vs-Asian
7.272000E-01
AfricanAmerican-vs-Asian
5.419600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.127400E-01
Normal-vs-Female
3.519800E-01
Male-vs-Female
6.602200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.352600E-01
Normal-vs-Age(41-60Yrs)
3.606600E-01
Normal-vs-Age(61-80Yrs)
3.072600E-01
Normal-vs-Age(81-100Yrs)
5.586400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.969970E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.703600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.793380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.097000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.945400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.006000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.884200E-01
Normal-vs-Daily Drinker
2.466600E-01
Normal-vs-Weekly Drinker
3.812600E-01
Normal-vs-Occasional Drinker
6.760800E-01
Normal-vs-Social Drinker
4.050200E-01
Non Drinker-vs-Daily Drinker
7.391800E-01
Non Drinker-vs-Weekly Drinker
7.110200E-01
Non Drinker-vs-Occasional Drinker
2.376200E-01
Non Drinker-vs-Social Drinker
5.558800E-01
Daily Drinker-vs-Weekly Drinker
5.355200E-01
Daily Drinker-vs-Occasional Drinker
1.728800E-01
Daily Drinker-vs-Social Drinker
4.034000E-01
Weekly Drinker-vs-Occasional Drinker
4.993000E-01
Weekly Drinker-vs-Social Drinker
8.570400E-01
Occasional Drinker-vs-Social Drinker
5.941000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.106800E-01
Normal-vs-Grade 2
2.782000E-02
Normal-vs-Grade 3
7.951900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.629580E-01
Grade 1-vs-Grade 3
7.166000E-02
Grade 1-vs-Grade 4
2.106800E-01
Grade 2-vs-Grade 3
3.580800E-01
Grade 2-vs-Grade 4
2.782000E-02
Grade 3-vs-Grade 4
7.951900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.013800E-01
Normal-vs-NonDiabetic
3.245400E-01
Diabetic-vs-NonDiabetic
3.239600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.031830E-01
Normal-vs-NoPancreatitis
3.190200E-01
Pancreatitis-vs-NoPancreatitis
4.687000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.032000E-01
Normal-vs-N1
3.066600E-01
N0-vs-N1
6.421400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.585400E-01
Normal-vs-TP53-NonMutant
4.442800E-01
TP53-Mutant-vs-TP53-NonMutant
6.838400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
